RxDoctor Payments Data

Tina Compton

Family Medicine · Grundy, VANPI 1700940327

Payments from drug & device makers

$437in general payments, 2019–2025

Across 20 payments — averaging $21.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$203
  • Otsuka America Pharmaceutical, Inc.$87
  • Abbott$33
  • Bayer$31
  • Biohaven Pharmaceutical Holding Company Ltd.$21
  • AstraZeneca$17
  • plus $46 from 4 others

What the payments were for

  • Food & beverage$437100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$437 in reported general payments places this provider in the 55th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$45,380
Medicare patients
123
Services billed
1,075

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide94$116,338
EliquisApixaban126$87,554
OzempicSemaglutide73$83,236
TrulicityDulaglutide43$47,558
LinzessLinaclotide36$27,541
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,093$20,457
JanuviaSitagliptin Phosphate29$18,240
WegovySemaglutide12$18,083
Dexlansoprazole DrDexlansoprazole76$17,543
VraylarCariprazine Hcl12$16,711
Tresiba Flextouch U-200Insulin Degludec22$13,932
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$11,519
ErythromycinErythromycin Base12$8,759
Gabapentin861$8,732
Lantus SolostarInsulin Glargine,hum.Rec.Anlog54$8,536

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$15$101,31985 claims
AbbVieLinzess, Vraylar, Synthroid$203$48,144115 claims
AstraZenecaSymbicort$17$5,09718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Grundy

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →